Skip to main content
Clinical Trials/JPRN-UMIN000050014
JPRN-UMIN000050014
Recruiting
Phase 2

Phase II study of TransOral Surgery for local recurrence after radiotherapy for head and neck cancer in Japan - TOS-J 3 trial

ational Cancer Center Hospital East0 sites28 target enrollmentJanuary 11, 2023

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
ational Cancer Center Hospital East
Enrollment
28
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
January 11, 2023
End Date
December 31, 2031
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
ational Cancer Center Hospital East

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\) Patient has two or more multiple cancers of the head and neck region other than the primary lesion at the time of enrollment. 2\) Incurable multiple head and neck cancers or double cancers 3\) Scheduled to receive chemotherapy (including endocrine therapy, molecular targeted therapy, or immune checkpoint inhibitors) for multiple head and neck cancers or double cancers at the time of enrollment. 4\) Women who might be pregnant 5\) Participation in the study is precluded by the presence of psychosis or psychiatric symptoms. 6\) Active infection (a fever of \>\=38 degrees and bacterial infection confirmed on imaging studies or bacteriologic examinations) 7\) Investigator determines that the patient is ineligible.

Outcomes

Primary Outcomes

Not specified

Similar Trials